Suppr超能文献

在线近红外光谱作为一种过程分析技术(PAT)工具,用于控制工业有晶种原料药结晶。

On-line near infrared spectroscopy as a Process Analytical Technology (PAT) tool to control an industrial seeded API crystallization.

机构信息

UCB Pharma, Analytical Development Chemicals, Chemin du Foriest, 1420 Braine-l'Alleud, Belgium.

出版信息

J Pharm Biomed Anal. 2013 Sep;83:194-201. doi: 10.1016/j.jpba.2013.05.015. Epub 2013 May 20.

Abstract

The final step of an active pharmaceutical ingredient (API) manufacturing synthesis process consists of a crystallization during which the API and residual solvent contents have to be quantified precisely in order to reach a predefined seeding point. A feasibility study was conducted to demonstrate the suitability of on-line NIR spectroscopy to control this step in line with new version of the European Medicines Agency (EMA) guideline [1]. A quantitative method was developed at laboratory scale using statistical design of experiments (DOE) and multivariate data analysis such as principal component analysis (PCA) and partial least squares (PLS) regression. NIR models were built to quantify the API in the range of 9-12% (w/w) and to quantify the residual methanol in the range of 0-3% (w/w). To improve the predictive ability of the models, the development procedure encompassed: outliers elimination, optimum model rank definition, spectral range and spectral pre-treatment selection. Conventional criteria such as, number of PLS factors, R(2), root mean square errors of calibration, cross-validation and prediction (RMSEC, RMSECV, RMSEP) enabled the selection of three model candidates. These models were tested in the industrial pilot plant during three technical campaigns. Results of the most suitable models were evaluated against to the chromatographic reference methods. Maximum relative bias of 2.88% was obtained about API target content. Absolute bias of 0.01 and 0.02% (w/w) respectively were achieved at methanol content levels of 0.10 and 0.13% (w/w). The repeatability was assessed as sufficient for the on-line monitoring of the 2 analytes. The present feasibility study confirmed the possibility to use on-line NIR spectroscopy as a PAT tool to monitor in real-time both the API and the residual methanol contents, in order to control the seeding of an API crystallization at industrial scale. Furthermore, the successful scale-up of the method proved its capability to be implemented in the manufacturing plant with the launch of the new API process.

摘要

原料药(API)制造合成工艺的最后一步是结晶过程,在此过程中必须精确地定量 API 和残留溶剂的含量,以达到预定的晶种点。进行了一项可行性研究,以证明在线近红外(NIR)光谱法符合欧洲药品管理局(EMA)新指南[1]的要求,用于控制该步骤的适用性。在实验室规模上使用统计实验设计(DoE)和多元数据分析(如主成分分析(PCA)和偏最小二乘(PLS)回归)开发了定量方法。建立了 NIR 模型,以定量 API 在 9-12%(w/w)范围内,定量残留甲醇在 0-3%(w/w)范围内。为了提高模型的预测能力,开发过程包括:剔除异常值、定义最佳模型秩、选择光谱范围和光谱预处理。使用常规标准(如 PLS 因子数量、R(2)、校准的均方根误差(RMSEC)、交叉验证和预测(RMSECV、RMSEP))选择了三个模型候选者。在三个技术活动期间,在工业中试工厂中对这些模型进行了测试。对最适合的模型的结果进行了评估,并与色谱参考方法进行了比较。API 目标含量的最大相对偏差为 2.88%。在甲醇含量分别为 0.10%和 0.13%(w/w)时,分别实现了 0.01%和 0.02%(w/w)的绝对偏差。重复性足以在线监测这 2 种分析物。本可行性研究证实了使用在线 NIR 光谱法作为 PAT 工具实时监测 API 和残留甲醇含量的可能性,以便在工业规模上控制 API 结晶的晶种。此外,方法的成功放大证明了其在制造工厂中实施的能力,随着新 API 工艺的推出。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验